Sign inGet started

Patel Gautam

Insider CIK 1738054 · SPB Director · AMRX Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AMRX Amneal Pharmaceuticals, In A Award2026-08-102026-08-12283,632— $0283,632SEC↗
AMRX Amneal Pharmaceuticals, In A Award2026-08-102026-08-12283,632— —283,632SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise deriv2026-05-072026-05-0834,819— $00SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise2026-05-072026-05-0834,819— $01,643,963SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2026-05-062026-05-0819,824— $019,824SEC↗
SPB Spectrum Brands Holdings, A Award2025-12-122025-12-164,602— $022,141SEC↗
AMRX Amneal Pharmaceuticals, In S Sale2025-06-162025-06-1894,906$8.02 $761.1K1,609,144SEC↗
AMRX Amneal Pharmaceuticals, In S Sale2025-06-102025-06-1256,426$8.02 $452.5K1,704,050SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2025-05-062025-05-0834,819— $034,819SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise deriv2025-05-052025-05-0840,258— $00SEC↗
AMRX Amneal Pharmaceuticals, In S Sale2025-05-052025-05-064,900$8.00 $39.2K1,720,218SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise2025-05-052025-05-0840,258— $01,760,476SEC↗
AMRX Amneal Pharmaceuticals, In S Sale2025-05-022025-05-063,768$8.00 $30.1K1,725,118SEC↗
AMRX Amneal Pharmaceuticals, In S Sale2025-04-012025-04-0280,000$8.30 $664.0K1,728,886SEC↗
AMRX Amneal Pharmaceuticals, In S Sale2025-03-032025-03-0580,000$8.90 $712.0K1,808,886SEC↗
AMRX Amneal Pharmaceuticals, In S Sale2025-02-032025-02-0580,000$8.14 $651.2K1,888,886SEC↗
AMRX Amneal Pharmaceuticals, In S Sale2025-01-082025-01-1062,590$8.01 $501.3K1,968,886SEC↗
AMRX Amneal Pharmaceuticals, In S Sale2025-01-022025-01-0617,410$8.01 $139.5K2,031,476SEC↗
SPB Spectrum Brands Holdings, A Award2024-11-192024-11-202,770$90.26 $250.0K17,539SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise deriv2024-05-102024-05-1476,453— $00SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise2024-05-102024-05-1476,453— $02,048,886SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2024-05-022024-05-0640,258— $040,258SEC↗
AMRX Amneal Pharmaceuticals, In J Other2024-01-012024-01-0333,458,067— $0374,318SEC↗
AMRX Amneal Pharmaceuticals, In G Gift2024-01-012024-01-031,598,115— $01,972,433SEC↗
SPB Spectrum Brands Holdings, A Award2023-11-242023-11-283,775— $014,769SEC↗
AMRX Amneal Pharmaceuticals, In J Other deriv2023-11-072023-11-0817,497,336— $00SEC↗
AMRX Amneal Pharmaceuticals, In J Other2023-11-072023-11-0817,497,336— $030,384,769SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise deriv2023-05-102023-05-1180,128— $00SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise2023-05-102023-05-1180,128— $0374,318SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2023-05-092023-05-1176,453— $076,453SEC↗
SPB Spectrum Brands Holdings, A Award2022-11-252022-11-295,020— $010,994SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2022-05-092022-05-1080,128— $080,128SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise deriv2022-05-082022-05-1035,406— $00SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise2022-05-082022-05-1035,406— $0294,190SEC↗
AMRX Amneal Pharmaceuticals, In P Buy2021-12-172021-12-2050,000$4.21 $210.5K258,784SEC↗
SPB Spectrum Brands Holdings, A Award2021-12-152021-12-172,441— $05,974SEC↗
AMRX Amneal Pharmaceuticals, In J Other2021-12-012023-12-013,073,298— $015,960,731SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise deriv2021-05-062021-05-0746,218— $00SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise2021-05-062021-05-0746,218— $0208,784SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2021-05-052021-05-0735,406— $035,406SEC↗
SPB Spectrum Brands Holdings, A Award2020-12-222020-12-233,533— $03,533SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise deriv2020-05-072020-05-076,459— $00SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise2020-05-072020-05-076,459— $0162,566SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2020-05-052020-05-0746,218— $046,218SEC↗
AMRX Amneal Pharmaceuticals, In P Buy2020-03-032020-03-10117,889$3.94 $464.5K156,107SEC↗
AMRX Amneal Pharmaceuticals, In P Buy2020-03-022020-03-1032,111$3.88 $124.6K38,218SEC↗
AMRX Amneal Pharmaceuticals, In C Conversion deriv2019-11-112019-11-1212,887,433— $017,497,336SEC↗
AMRX Amneal Pharmaceuticals, In C Conversion2019-11-112019-11-1212,887,433— $012,887,433SEC↗
AMRX Amneal Pharmaceuticals, In J Other2019-11-112019-11-1212,887,433— $017,497,336SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise deriv2019-05-082019-05-086,107— $00SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise2019-05-082019-05-086,107— $06,107SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2019-05-062019-05-0828,044— $028,044SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2019-05-062019-05-086,459— $06,459SEC↗
AMRX Amneal Pharmaceuticals, In J Other deriv2018-07-052018-07-0930,384,769— $030,384,769SEC↗
AMRX Amneal Pharmaceuticals, In J Other2018-07-052018-07-0930,384,769— $030,384,769SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2018-05-072018-05-096,107— $06,107SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2018-05-072018-05-0924,977— $024,977SEC↗